Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Thinking about hiring a financial advisor in your 20s? Discover key considerations to ensure you choose the right professional for you.
24,143 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
The ripple (xrp) price down narrative dominates crypto desks as XRP slides toward $1 amid a market-wide pullback. Her...
The XRP Ledger is set to deploy core software version 3.2.0 next week, bringing a rename to XRPLD and notable efficie...
Tech stocks retreat sparked a broader market pause, but analysts insist the stock market isn’t crashing — it’s a rota...
With the MiCA deadline looming, a vast majority of EU crypto firms have not completed full licensing. Only a fraction...
META AI forecasts a potential XRP rally to multi-dollar levels by late-2026, hinging on regulatory clarity, network a...
Bitcoin price crashes below the key $60,000 level as MicroStrategy shares slide, signaling renewed pressure across di...
Comcast plans a two‑unit split, separating media operations from connectivity services. Investors responded with a 24...
New data shows half of global energy is lost as heat within the system. This article examines how policy and markets ...
Tom Zschach, who led SWIFT's digital asset strategy for six years, publicly dismissed XRP partnership rumors on July ...
CHLA pushes for an FHA pilot that would pay lenders directly for sub-$100K mortgages, arguing the move is needed to u...
As Pi Network marks its Open Network’s first anniversary, supporters and critics clash over migration progress and th...